Hepatitis C Pharmacogenetics: State of the Art in 2010

被引：125

作者：

Afdhal, Nezam H. ^{[1
,2
]}

McHutchison, John G. ^{[3
]}

Zeuzem, Stefan ^{[5
]}

Mangia, Alessandra ^{[6
]}

Pawlotsky, Jean-Michel ^{[7
]}

Murray, Jeffrey S. ^{[8
]}

Shianna, Kevin V. ^{[4
]}

Tanaka, Yasuhito ^{[9
,10
]}

Thomas, David L. ^{[11
]}

Booth, David R. ^{[12
]}

Goldstein, David B. ^{[4
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Boston, MA 02215 USA

[3] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA

[4] Duke Univ, Med Ctr, Ctr Human Genome Variat, Durham, NC USA

[5] JW Goethe Univ Hosp, Dept Internal Med, Frankfurt, Germany

[6] IRCCS Casa Sollievo Sofferenza, Div Gastroenterol, San Giovanni Rotondo, Italy

[7] Univ Paris EST, Hop Henri Mondor, Dept Virol, Creteil, France

[8] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[9] Nagoya City Univ, Dept Virol, Nagoya, Aichi, Japan

[10] Nagoya City Univ, Liver Unit, Nagoya, Aichi, Japan

[11] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA

[12] Univ Sydney, Westmead Millennium Inst, Sydney, NSW, Australia

来源：

HEPATOLOGY | 2011年 / 53卷 / 01期

关键词：

PEGYLATED INTERFERON-ALPHA; GENETIC-VARIATION; IL28B POLYMORPHISM; RIBAVIRIN THERAPY; IFN-LAMBDA; GENOTYPE; PEGINTERFERON; EXPRESSION;

D O I：

10.1002/hep.24052

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In 2009, a correlated set of polymorphisms in the region of the interleukin-28B (IL28B) gene were associated with clearance of genotype 1 hepatitis C virus (HCV) in patients treated with pegylated interferon-alfa and ribavirin. The same polymorphisms were subsequently associated with spontaneous clearance of HCV in untreated patients. The link between IL28B genotype and HCV clearance may impact decisions regarding initiation of current therapy, the design and interpretation of clinical studies, the economics of treatment, and the process of regulatory approval for new anti-HCV therapeutic agents. (HEPATOLOGY 2011;53:336-345)

引用

页码：336 / 345

页数：10

共 26 条

[1] Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
Ank, N
West, H
Bartholdy, C
Eriksson, K
Thomsen, AR
Paludan, SR
[J]. JOURNAL OF VIROLOGY, 2006, 80 (09) : 4501 - 4509
[2] An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity
Ank, Nina
Iversen, Marie B.
Bartholdy, Christina
Staeheli, Peter
Hartmann, Rune
Jensen, Uffe B.
Dagnaes-Hansen, Frederik
Thomsen, Allan R.
Chen, Zhi
Haugen, Harald
Klucher, Kevin
Paludan, Soren R.
[J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (04) : 2474 - 2485
[3] Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
Coccia, EM
Severa, M
Giacomini, E
Monneron, D
Remoli, ME
Julkunen, I
Cella, M
Lande, R
Uzé, G
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) : 796 - 805
[4] Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Conjeevaram, Hari S.
Fried, Michael W.
Jeffers, Lennox J.
Terrault, Norah A.
Wiley-Lucas, Thelma E.
Afdhal, Nezam
Brown, Robert S.
Belle, Steven H.
Hoofnagle, Jay H.
Kleiner, David E.
Howell, Charles D.
[J]. GASTROENTEROLOGY, 2006, 131 (02) : 470 - 477
[5] Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes
Doyle, Sean E.
Schreckhise, Heidi
Khuu-Duong, Kien
Henderson, Katherine
Rosler, Robert
Storey, Harold
Yao, Lena
Liu, Hong
Barahmand-pour, Fariba
Sivakumar, Pallavur
Chan, Chung
Birks, Carl
Foster, Don
Clegg, Christopher H.
Wietzke-Braun, Perdita
Mihm, Sabine
Klucher, Kevin M.
[J]. HEPATOLOGY, 2006, 44 (04) : 896 - 906
[6] ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
Fellay, Jacques
Thompson, Alexander J.
Ge, Dongliang
Gumbs, Curtis E.
Urban, Thomas J.
Shianna, Kevin V.
Little, Latasha D.
Qiu, Ping
Bertelsen, Arthur H.
Watson, Mark
Warner, Amelia
Muir, Andrew J.
Brass, Clifford
Albrecht, Janice
Sulkowski, Mark
McHutchison, John G.
Goldstein, David B.
[J]. NATURE, 2010, 464 (7287) : 405 - 408
[7] Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, Dongliang
Fellay, Jacques
Thompson, Alexander J.
Simon, Jason S.
Shianna, Kevin V.
Urban, Thomas J.
Heinzen, Erin L.
Qiu, Ping
Bertelsen, Arthur H.
Muir, Andrew J.
Sulkowski, Mark
McHutchison, John G.
Goldstein, David B.
[J]. NATURE, 2009, 461 (7262) : 399 - 401
[8] Herrmann E, 2000, ANTIVIR THER, V5, P85
[9] Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Honda, Masao
Sakai, Akito
Yamashita, Tatsuya
Nakamoto, Yasunari
Mizukoshi, Eishiro
Sakai, Yoshio
Yamashita, Taro
Nakamura, Mikiko
Shirasaki, Takayoshi
Horimoto, Katsuhisa
Tanaka, Yasuhito
Tokunaga, Katsushi
Mizokami, Masashi
Kaneko, Shuichi
[J]. GASTROENTEROLOGY, 2010, 139 (02) : 499 - 509
[10] IL28B GENETIC VARIATION ASSOCIATED WITH EARLY VIRAL KINETICS AND SVR IN HCV GENOTYPE 1 THE VIRAHEP-C STUDY
Howell, C. D.
Thompson, A. J.
Ryan, K.
Zambeeli, S.
Gorden, A.
Fried, M.
Afdhal, N. H.
McHutchison, J. G.
Shianne, K. V.
Mitchell, B.
Goldstein, D. B.
Shuldiner, A.
[J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S451 - S451

← 1 2 3 →